Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 known ✓ | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 known ✓ | P32297 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.41 |
| ▸ | BBOX1 | O75936 | 6/20 | 0.38 |
| ▸ | GALR3 | O60755 | 1/20 | 0.37 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL17888821 | 0.92 | MEN1 (0.43) | MEN1LMNAKMT2ACYP3A4SLC5A7 | |
| Acetic Acid SCHEMBL15826260 | 0.91 | BBOX1 (0.42) | CA1MEN1LMNAKMT2ACYP3A4 | |
| Bicarbonate SCHEMBL8995792 | 0.89 | MEN1 (0.41) | MEN1LMNAKMT2ACYP3A4SLC5A7 | |
| Bicarbonate SCHEMBL7574736 | 0.89 | LMNA (0.41) | MEN1LMNAKMT2ACYP3A4SLC5A7 | |
| Acetic Acid SCHEMBL15820391 | 0.89 | BBOX1 (0.41) | CA1MEN1LMNAKMT2ACYP3A4 | |
| Acetic Acid SCHEMBL15820741 | 0.87 | BBOX1 (0.39) | CA1MEN1LMNAKMT2ABBOX1 | |
| Acetic Acid SCHEMBL2920415 | 0.83 | DNM1 (0.46) | CA1MEN1LMNAKMT2ACYP3A4 | |
| Choline SCHEMBL316506 | 0.83 | LMNA (0.63) | CA1MEN1LMNAKMT2ACYP3A4 | |
| Acetic Acid SCHEMBL28437505 | 0.83 | DNM1 (0.53) | BBOX1PSMD14PLA2G1BMMP2RAD52 | |
| Acetic Acid SCHEMBL28670247 | 0.83 | DNM1 (0.53) | BBOX1PSMD14PLA2G1BMMP2RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120026412-A | Mushroom fiber electrode and preparation method thereof | 武汉纺织大学 | 2025-05-23 | — | — | CN | claimed |
| CN-119956526-A | Mushroom fiber, green preparation method and application thereof | 武汉纺织大学 | 2025-05-09 | — | — | CN | claimed |
| CN-120026412-A | Mushroom fiber electrode and preparation method thereof | 武汉纺织大学 | 2025-05-23 | — | — | CN | disclosed |
| CN-119956526-A | Mushroom fiber, green preparation method and application thereof | 武汉纺织大学 | 2025-05-09 | — | — | CN | disclosed |
| US-20150335547-A1 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | COLGATE-PALMOLIVE COMPANY (US) | 2015-11-26 | — | — | US | disclosed |
| EP-2934469-A2 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | Colgate-Palmolive Company (US) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014098871-A2 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | COLGATE-PALMOLIVE COMPANY (US) | 2014-06-26 | — | — | WO | disclosed |
| EP-1663486-A4 | LOW-ODOR CATALYST FOR ISOCYANATE-DERIVED FOAMS AND ELASTOMERS | HUNTSMAN SPEC CHEM CORP (US) | 2008-06-11 | — | — | EP | disclosed |
| US-20070282026-A1 | Low-Odor Catalyst for Isocyanate-Derived Foams and Elastomers | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2007-12-06 | — | — | US | disclosed |
| EP-1663486-A2 | LOW-ODOR CATALYST FOR ISOCYANATE-DERIVED FOAMS AND ELASTOMERS | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005009601-A2 | LOW-ODOR CATALYST FOR ISOCYANATE-DERIVED FOAMS AND ELASTOMERS | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2005-02-03 | — | — | WO | disclosed |
| EP-0523483-B1 | Process for the preparation of screen fractions of bead-form, expandable styrene polymers prepared by suspension polymerisation | BASF AG (DE) | 1995-12-06 | — | — | EP | disclosed |
| EP-0470455-B1 | Antistatic expansible polystyrene pearls | BASF AG (DE) | 1995-09-27 | — | — | EP | disclosed |
| US-5286756-A | With antistatic agent; metal-free coating | BASF AKTIENGESELLSCHAFT (DE) | 1994-02-15 | — | — | US | disclosed |
| EP-0523483-A1 | Process for the preparation of screen fractions of bead-form, expandable styrene polymers prepared by suspension polymerisation | BASF Aktiengesellschaft (DE) | 1993-01-20 | — | — | EP | disclosed |
| US-5110835-A | Coated with hydroxyl-containing quaternary ammonium salt | BASF AKTIENGESELLSCHAFT (DE) | 1992-05-05 | — | — | US | disclosed |
| EP-0470455-A2 | Antistatic expansible polystyrene pearls | BASF Aktiengesellschaft (DE) | 1992-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150335547-A1 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | MCOLN3, TAS2R39, TAS2R40 | CHRNB4 3065/4885CHRNA3 2311/4885CA1 1525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.